Clinical Trial Update: Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated the effects of Visbiome Extra Strength probiotic on the gut microbiome and immune activation markers in HIV-1 infection; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Visbiome Extra Strength

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED | Results posted: 2018-06-27